{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:16:52Z","timestamp":1762521412586,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ejps.2011.04.010","type":"journal-article","created":{"date-parts":[[2011,5,2]],"date-time":"2011-05-02T23:32:20Z","timestamp":1304379140000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies"],"prefix":"10.1016","volume":"43","author":[{"given":"V.V.S.","family":"Rajendra Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ietje","family":"Kathmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.C.","family":"Mayur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2011.04.010_b0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2362.2004.01411.x","article-title":"Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and buthionine sulfoximine","volume":"34","author":"Akan","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejps.2011.04.010_b0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/mas.10008","article-title":"Practical implications of some recent studies in ESI fundamentals","volume":"20","author":"Cech","year":"2001","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ejps.2011.04.010_b0015","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1021\/bi00856a017","article-title":"Properties of cyclic-3\u2032,5\u2032nucleotide phosphodiesterase from rat brain","volume":"6","author":"Cheung","year":"1967","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejps.2011.04.010_b0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)00045-6","article-title":"Pharmacology of drugs that alter multidrug resistance in cancer","volume":"42","author":"Ford","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2011.04.010_b0025","first-page":"5056","article-title":"Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells","volume":"44","author":"Ganapathi","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.04.010_b0030","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1021\/ja00016a069","article-title":"Detection of noncovalent receptor ligand complexes by mass spectrometry","volume":"113","author":"Ganem","year":"1991","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2011.04.010_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-005-0141-1","article-title":"Multidrug resistance proteins and folate supplementation: therapeutic implications for antifolates and other classes of drugs in cancer treatment","volume":"58","author":"Hooijberg","year":"2006","journal-title":"Cancer Chem. Pharm."},{"key":"10.1016\/j.ejps.2011.04.010_b0040","first-page":"15","article-title":"Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention","volume":"10","author":"Kaye","year":"1998","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ejps.2011.04.010_b0045","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0277-5379(91)90142-Z","article-title":"Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing","volume":"27","author":"Keepers","year":"1991","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejps.2011.04.010_b0050","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1002\/anie.200353051","article-title":"Partitioning of solvent effects and intrinsic interactions in biological recognition","volume":"43","author":"Kitova","year":"2004","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejps.2011.04.010_b0055","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1093\/nar\/gki904","article-title":"Induction of unique structural changes in guanine-rich DNA regions by the triazoloacridone C-1305 a topoisomerase II inhibitor with antitumor activities","volume":"33","author":"Lemke","year":"2005","journal-title":"Nucleic Acids Res."},{"year":"1988","series-title":"Flourine Containing Molecules, Structure, Reactivity, Synthesis and Applications","author":"Liebman","key":"10.1016\/j.ejps.2011.04.010_b0060"},{"key":"10.1016\/j.ejps.2011.04.010_b0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev.bi.58.070189.002031","article-title":"DNA topoisomerase poisons as antitumor drugs","volume":"58","author":"Liu","year":"1989","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.ejps.2011.04.010_b0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/157340608785700180","article-title":"Synthesis of 2-methyl N10-substituted acridones as selective inhibitors of multidrug resistance (MDR) associated protein in cancer cells","volume":"4","author":"Mayur","year":"2008","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejps.2011.04.010_b0075","first-page":"223","article-title":"Molecular mechanisms of action of calmodulin","volume":"44","author":"Means","year":"1988","journal-title":"Recent Prog. Hormone Res.."},{"key":"10.1016\/j.ejps.2011.04.010_b0080","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0006-2952(77)90108-3","article-title":"Correlation of biological data with physicochemical properties among the vinca alkaloids and their congeners","volume":"26","author":"Owellen","year":"1977","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2011.04.010_b0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3565(25)33233-7","article-title":"Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships","volume":"222","author":"Prozialeck","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2011.04.010_b0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/nar\/gnf081","article-title":"Determination of affinity, stoichiometry and sequence selectivity of minor groove binders complexes with double-stranded oligodeoxynucleotides by electrospray ionization mass spectrometry","volume":"30","author":"Rosu","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejps.2011.04.010_b0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijms.2005.11.027","article-title":"Positive and negative ion mode ESI-MS and MS\/MS for studying drug\u2013DNA complexes","volume":"253","author":"Rosu","year":"2006","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.ejps.2011.04.010_b0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0014-827X(02)01229-6","article-title":"The medicinal chemistry of multidrug resistance (MDR) reversing drugs","volume":"57","author":"Teodri","year":"2002","journal-title":"IL Farmaco."},{"key":"10.1016\/j.ejps.2011.04.010_b0105","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.bjc.6690791","article-title":"The acridonecarboxamide GF120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells","volume":"81","author":"Traunecker","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2011.04.010_b0110","first-page":"4730","article-title":"Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors","volume":"42","author":"Tsuruo","year":"1982","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.04.010_b0115","first-page":"2267","article-title":"Potentiation of vincristine and adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors","volume":"43","author":"Tsuruo","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2011.04.010_b0120","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bjc.6690169","article-title":"Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918","volume":"79","author":"Wallstab","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejps.2011.04.010_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/jm00163a009","article-title":"5-[(Aminoalkyl)amino] imidazo[4,5,1-de]acridin-6-ones as a novel class of antineoplastic agents synthesis and biological activity","volume":"33","author":"Wieslaw","year":"1990","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711001059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098711001059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:44:56Z","timestamp":1760528696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098711001059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0928098711001059"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2011.04.010","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2011.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}